Process for the Manufacture of PTHrP Analogue
2018 Ricci; A.; Guryanov; I.; De Paola; I.; Cabri W; Orlandin; A.
NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
2010 Hanessian S.; Auzzas L.; Larsson A.; Giannini G.; Cabri W
Process for the production of Pen V acylase from Streptomyces Lavendula
2005 De La Mata Riesco; I.; Torres Bacete; J.; Torres Guzman; R.; Arroyo Sanchez; M.; Castillon Borreguero; M.P.; Acabel Sarabia; A.; Rodriguez Sainz; M.; Barredo Fuente; J.L.; Moreno Valle; M.A.; Lopez Ortiz; J.F.; Cabri W; Garcia Lopez; J.L.
ARYL TRIAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITY
2010 Giannini; G.; Cabri W; Taddei; M.; Ferrini; S.
OXIME CARBAMOYL DERIVATIVES AS MODULATORS OF FATTY ACID AMIDES HYDROLASE
2009 Minetti; P.; Cabri W; Borsini; F.; Caprioli; A.; Penco; S.; Dellavalle; S.; Merlini; L.; Maccarone; M.
Aryl isoxazole compounds with antitumoral Activities
2009 Carminati; P.; Pisano; C.; Giannini; G.; Cabri W; Simoni; D.; Barucchello; R: Singrossi; CArminati; S.
Crystalline solvate forms of cabazitaxel
2013 Peterlongo; F.; Ciceri; D.; Gambini; A.; Domenighini; L; Cabri w
A Method for Production of High Purity Icatibant"
2018 Ricci; A.; Borgogno; A.; Gurianov; I.; Viola; A.; Cabri W; Pozzebon; A.
Cefalosporina C Acilasi
2005 Pollegioni L.; Pilone M.; Molla G.; Cucchetti E.; Verga R.; Cabri W
New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
2013 Peterlongo; F.; Ciceri; D.; Gambini; A.; Domenighini; L.; Cabri w
Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides
2007 Cabri W; Alpegiani; Benedetti; F.; M.Rodriquez; Botta; C.
A Process For The Preparation Of Xylene Linked Cyclam Compounds
2016 Lahiri; S.; Cabri W
An Improved Process for the Preparation of Ixazomib citrate
2018 Pandey; M.K.; Shukla S.P.; Tiwari R.N.; Sokhi; S.S.; Singh G.; Lahiri S:; Cabri W
A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof
2019 Cabri W; Lahiri; S.; Gupta; N.; Azim; A.; Tomar; V.S
Process for The Manufacture of GLP-1 Analogues
2018 Cabri W; Ricci; A.; Guryanov; I.; Incisivo; M. P.; Orlandin; A.
Crystalline Forms Of Per-chloro-gamma-cyclodextrines
2015 Zanon; J.; Ricci; A.; Lahiri; S.; Cabri W
Polymorphic Forms Of Afatinib Free Base and Afatinib Dimaleate
2016 Lahiri; S.; Cabri W
OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS
2010 Cabri W; Minetti; P.; Piersanti; G.; Tarzia; G.
Identifying wrong-way travel events
2018 Francesco Sambo, Luca Bravi, Samuele Salti, Leonardo Taccari, Matteo Simoncini, Alessandro Lori, Leonardo Sarti, Jason M Koch
Use of microbial communities for human and animal health
2016 Possemier S, Marzorati M, Van De Wiele T, Scheirlinck I, Van den Abeele P, Bolca S, Gottardi D
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Process for the Manufacture of PTHrP Analogue | Ricci; A.; Guryanov; I.; De Paola; I.; Cabri W; Orlandin; A. | 2018-01-01 | - | - | 6.01 Brevetto | - |
| NON-NATURAL MACROCYCLIC AMIDE HDAC6 INHIBITOR COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS | Hanessian S.; Auzzas L.; Larsson A.; Giannini G.; Cabri W | 2010-01-01 | - | - | 6.01 Brevetto | - |
| Process for the production of Pen V acylase from Streptomyces Lavendula | De La Mata Riesco; I.; Torres Bacete; J.; Torres Guzman; R.; Arroyo Sanchez; M.; Castillon Borreg...uero; M.P.; Acabel Sarabia; A.; Rodriguez Sainz; M.; Barredo Fuente; J.L.; Moreno Valle; M.A.; Lopez Ortiz; J.F.; Cabri W; Garcia Lopez; J.L. | 2005-01-01 | - | - | 6.01 Brevetto | - |
| ARYL TRIAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITY | Giannini; G.; Cabri W; Taddei; M.; Ferrini; S. | 2010-01-01 | - | - | 6.01 Brevetto | - |
| OXIME CARBAMOYL DERIVATIVES AS MODULATORS OF FATTY ACID AMIDES HYDROLASE | Minetti; P.; Cabri W; Borsini; F.; Caprioli; A.; Penco; S.; Dellavalle; S.; Merlini; L.; Maccaron...e; M. | 2009-01-01 | - | - | 6.01 Brevetto | - |
| Aryl isoxazole compounds with antitumoral Activities | Carminati; P.; Pisano; C.; Giannini; G.; Cabri W; Simoni; D.; Barucchello; R: Singrossi; CArminat...i; S. | 2009-01-01 | - | - | 6.01 Brevetto | - |
| Crystalline solvate forms of cabazitaxel | Peterlongo; F.; Ciceri; D.; Gambini; A.; Domenighini; L; Cabri w | 2013-01-01 | - | - | 6.01 Brevetto | - |
| A Method for Production of High Purity Icatibant" | Ricci; A.; Borgogno; A.; Gurianov; I.; Viola; A.; Cabri W; Pozzebon; A. | 2018-01-01 | - | - | 6.01 Brevetto | - |
| Cefalosporina C Acilasi | Pollegioni L.; Pilone M.; Molla G.; Cucchetti E.; Verga R.; Cabri W | 2005-01-01 | - | - | 6.01 Brevetto | - |
| New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof | Peterlongo; F.; Ciceri; D.; Gambini; A.; Domenighini; L.; Cabri w | 2013-01-01 | - | - | 6.01 Brevetto | - |
| Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides | Cabri W; Alpegiani; Benedetti; F.; M.Rodriquez; Botta; C. | 2007-01-01 | - | - | 6.01 Brevetto | - |
| A Process For The Preparation Of Xylene Linked Cyclam Compounds | Lahiri; S.; Cabri W | 2016-01-01 | - | - | 6.01 Brevetto | - |
| An Improved Process for the Preparation of Ixazomib citrate | Pandey; M.K.; Shukla S.P.; Tiwari R.N.; Sokhi; S.S.; Singh G.; Lahiri S:; Cabri W | 2018-01-01 | - | - | 6.01 Brevetto | - |
| A Process for Preparing Alectinib or a Pharmaceutically Acceptable Salt Thereof | Cabri W; Lahiri; S.; Gupta; N.; Azim; A.; Tomar; V.S | 2019-01-01 | - | - | 6.01 Brevetto | - |
| Process for The Manufacture of GLP-1 Analogues | Cabri W; Ricci; A.; Guryanov; I.; Incisivo; M. P.; Orlandin; A. | 2018-01-01 | - | - | 6.01 Brevetto | - |
| Crystalline Forms Of Per-chloro-gamma-cyclodextrines | Zanon; J.; Ricci; A.; Lahiri; S.; Cabri W | 2015-01-01 | - | - | 6.01 Brevetto | - |
| Polymorphic Forms Of Afatinib Free Base and Afatinib Dimaleate | Lahiri; S.; Cabri W | 2016-01-01 | - | - | 6.01 Brevetto | - |
| OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS | Cabri W; Minetti; P.; Piersanti; G.; Tarzia; G. | 2010-01-01 | - | - | 6.01 Brevetto | - |
| Identifying wrong-way travel events | Francesco Sambo, Luca Bravi, Samuele Salti, Leonardo Taccari, Matteo Simoncini, Alessandro Lori, ...Leonardo Sarti, Jason M Koch | 2018-01-01 | - | - | 6.01 Brevetto | - |
| Use of microbial communities for human and animal health | Possemier S, Marzorati M, Van De Wiele T, Scheirlinck I, Van den Abeele P, Bolca S, Gottardi D | 2016-01-01 | - | - | 6.01 Brevetto | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 6 - Brevetto813
Data di pubblicazione
- In stampa/Attività in corso3
- 2020 - 2025103
- 2010 - 2019405
- 2001 - 2009302
Keyword
- LUMINESCENZA7
- ANTIOXIDANTS6
- PLASMA CUTTING TORCHES6
- 14-CARBON ANALYSIS5
- 5-pyrimidinols5
- FLUORESCENZA5
- INHIBITORS5
- NANOPARTICELLE5
- PLASMA TORCH5
- POLYCARBONATES5
Lingua
- eng143
- ita139
- dut1
- spa1
Accesso al fulltext
- no fulltext807
- open6